Searched for
HOFFMAN LA ROCHE
Additional 45,000 vials of COVID-19 drug tocilizumab allocated to states: GowdaEarlier, 9,900 vials of tocilizumab were allocated to states and union territories on April 30, the chemicals and fertilizers minister adde...- Lupin launches generic influenza treatment capsules in the USThe capsules, in the strengths of 30 mg, 45 mg and 75 mg, are generic versions of Hoffman-La Roche Inc's Tamiflu capsules in the same stren...
- Aurobindo Pharma gets final USFDA nod for anti-viral drugAurobindo Pharma has received final approval from the US health regulator to manufacture and market anti-viral Valganciclovir tablets in th...
- Aurobindo Pharma gets final USFDA nod for osteoporosis drugDrug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market Ibandronate Sodium tablets, in the American mar...
- Cipla weighs legal options after Delhi HC's patent rulingDrug major Cipla is exploring all legal options in the wake of Delhi High Court's ruling that it has infringed Swiss drug major Hoffman-La ...
- Cipla asks government to revoke five patents held by NovartisCipla, India’s fifthlargest drugmaker by revenue, has asked the government to revoke five patents that Novartis holds on respiratory drug O...
- Roche and Cipla enter talks to settle Erlotinib patent rowThe development comes after a division bench of the Delhi HC referred the companies to a mediation that both firms chose to accept.
- Ten stocks in focus in Friday morning tradeIndian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.
- Intas settles patent litigation with Hoffmann-La Roche for capecitabine tabletAhmedabad-based drug maker, Intas Pharmaceuticals Ltd and its US-based wholly owned subsidiary Accord Healthcare Inc. has entered into a se...
- Dr Reddy's gets USFDA nod for generic Zenatane capsulesCompany has launched Accutane (Isotretinoin Capsules ) in the strengths of 20 mg and 40 mg on Mar 28 following the approval by the USFDA.
- How a myth is killing the rhinoWidely-entrenched beliefs about the miraculous properties of the rhino horn are leading to the animal’s massacre even though studies show t...
- Cipla has not infringed F Hoffman La-Roche's patent cancer drug: High CourtThe Delhi HC held that Indian pharma major Cipla has not infringed upon the patent right of Swiss drug co F Hoffman La-Roche on a cancer dr...
- Hetero Labs to produce Gilead's HIV drugs, through Medicines Patent PoolHyderabad based Hetero labs through an agreement with Geneva based Medicines Patent Pool will produce four key HIV drugs developed by Gilea...
- Hoffman La Roche loses patent suit against Matrix PharmaceuticalsRoche has lost a patent infringement suit against Matrix Pharma to prohibit the Indian firm from selling its anti-cancer drug Tarceva.
- Delhi High Court dismisses Roche plea on patentThe Delhi High Court on Friday allowed Indian pharmaceutical company Cipla to manufacture and sell the generic version of patented lung can...
- Stocks to Watch: Aditya Birla, Rel communications, HCL, Natco Pharma, Sun PharmaceuticalsMarkets are expected to be under pressure on Monday tracking sluggish cues from global markets.
- Sun Pharma gets FDA nod for torsemide tabletsSun Pharmaceutical Industries Ltd has received approval from the US Food and Drug Administration for torsemide tablets in multiple strength...
- Sun Pharma gets USFDA nod to market generic Demadex tabletsDrugs manufacturer Sun Pharmaceutical Industries Ltd has said that US Food and Drug Administration has given permission to market generic v...
- Elder Pharma, Israel co enter in-licensing dealMumbai-based Elder Pharmaceuticals has signed an exclusive in-licensing agreement with Israeli biotech company Enzymotec for the marketing ...
- Ranbaxy gets tentative USFDA nod for MidazolamRANBAXY Pharmaceuticals, a wholly-owned subsidiary of Ranbaxy Laboratories, on Friday announced it has received tentative US Food and Drug ...
Load More
